CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
+5.04%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$879M
AUM Growth
+$879M
(+24%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
17.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Tenaya Therapeutics
TNYA
|
$194M |
| 2 |
Surrozen
SRZN
|
$65.5M |
| 3 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
$60.5M |
Top Sells
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$88.8M |
| 2 |
RAPT Therapeutics
RAPT
|
$77.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $324M | 36.81% | 15,396,116 | – | – |
|
|
2
Tenaya Therapeutics
TNYA
$184M
| $194M | 22.08% | +9,400,290 | New | +$194M |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $99.7M | 11.34% | 4,768,181 | – | – |
|
4
Revolution Medicines
RVMD
$7.1B
| $92.1M | 10.47% | 3,347,245 | – | – |
|
|
5
Surrozen
SRZN
$104M
| $65.5M | 7.45% | +9,248,129 | New | +$65.5M |
|
|
EFTR
6
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $60.5M | 6.89% | +4,309,329 | New | +$60.5M |
|
|
7
RAPT Therapeutics
RAPT
$188M
| $43.5M | 4.95% | 1,402,008 -2,483,671 | -64% | -$77.1M |
|
|
CNST
8
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – | -2,626,631 | Closed | -$88.8M |
|